Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
Nat Med
    November 2020
  1. EDRIDGE AWD, Kaczorowska J, Hoste ACR, Bakker M, et al
    Seasonal coronavirus protective immunity is short-lasting.
    Nat Med. 2020;26:1691-1693.
    >> Share

    September 2020
  2. ABDEL-MOHSEN M, Richman D, Siliciano RF, Nussenzweig MC, et al
    Recommendations for measuring HIV reservoir size in cure-directed clinical trials.
    Nat Med. 2020;26:1339-1350.
    >> Share

    August 2020
  3. MALDINI CR, Claiborne DT, Okawa K, Chen T, et al
    Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo.
    Nat Med. 2020 Aug 31. pii: 10.1038/s41591-020-1039.
    >> Share

    May 2020
  4. ARUNACHALAM PS, Charles TP, Joag V, Bollimpelli VS, et al
    T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.
    Nat Med. 2020 May 11. pii: 10.1038/s41591-020-0858.
    >> Share

  5. IRUNGU EM, Baeten JM
    PrEP rollout in Africa: status and opportunity.
    Nat Med. 2020;26:655-664.
    >> Share

  6. MOYER TJ, Kato Y, Abraham W, Chang JYH, et al
    Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity.
    Nat Med. 2020;26:804.
    >> Share

    April 2020
  7. MOTHE B, Brander C
    Small steps forward for HIV vaccine development.
    Nat Med. 2020 Apr 2. pii: 10.1038/s41591-020-0837.
    >> Share

  8. HARPER J, Gordon S, Chan CN, Wang H, et al
    CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.
    Nat Med. 2020;26:519-528.
    >> Share

    March 2020
  9. COLBY DJ, Sarnecki M, Barouch DH, Tipsuk S, et al
    Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption.
    Nat Med. 2020 Mar 23. pii: 10.1038/s41591-020-0774.
    >> Share

  10. KAZER SW, Aicher TP, Muema DM, Carroll SL, et al
    Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection.
    Nat Med. 2020 Mar 23. pii: 10.1038/s41591-020-0799.
    >> Share

    February 2020
  11. MOYER TJ, Kato Y, Abraham W, Chang JYH, et al
    Engineered immunogen binding to alum adjuvant enhances humoral immunity.
    Nat Med. 2020 Feb 17. pii: 10.1038/s41591-020-0753.
    >> Share

  12. DUSSUPT V, Sankhala RS, Gromowski GD, Donofrio G, et al
    Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Nat Med. 2020 Feb 3. pii: 10.1038/s41591-019-0746.
    >> Share

  13. NIESSL J, Baxter AE, Mendoza P, Jankovic M, et al
    Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity.
    Nat Med. 2020 Feb 3. pii: 10.1038/s41591-019-0747.
    >> Share

    October 2019
  14. LUBAN J
    Retraction Note: The hidden cost of genetic resistance to HIV-1.
    Nat Med. 2019 Oct 8. pii: 10.1038/s41591-019-0636.
    >> Share

    September 2019
  15. YANT SR, Mulato A, Hansen D, Tse WC, et al
    A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model.
    Nat Med. 2019;25:1377-1384.
    >> Share

    June 2019
  16. STOWER H
    Preventing HIV transmission.
    Nat Med. 2019 Jun 6. pii: 10.1038/s41591-019-0490.
    >> Share

  17. LUBAN J
    The hidden cost of genetic resistance to HIV-1.
    Nat Med. 2019 Jun 3. pii: 10.1038/s41591-019-0481.
    >> Share

  18. WEI X, Nielsen R
    CCR5-32 is deleterious in the homozygous state in humans.
    Nat Med. 2019;25:909-910.
    >> Share

    May 2019

  19. HIV vaccines go to trial.
    Nat Med. 2019;25:703.
    >> Share

    April 2019
  20. CASKEY M, Klein F, Nussenzweig MC
    Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.
    Nat Med. 2019;25:547-553.
    >> Share

    March 2019
  21. BARRAS C
    Transplant success reignites interest in reprogramming cells against HIV.
    Nat Med. 2019 Mar 14. pii: 10.1038/d41591-019-00011.
    >> Share

    November 2018
  22. IMPERIAL MZ, Nahid P, Phillips PPJ, Davies GR, et al
    Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Nat Med. 2018 Nov 14. pii: 10.1038/s41591-018-0294.
    >> Share

    A stratified approach to tuberculosis treatment.
    Nat Med. 2018;24:1639-1641.
    >> Share

  24. IMPERIAL MZ, Nahid P, Phillips PPJ, Davies GR, et al
    A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Nat Med. 2018;24:1708-1715.
    >> Share

    September 2018
  25. BAR-ON Y, Gruell H, Schoofs T, Pai JA, et al
    Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals.
    Nat Med. 2018 Sep 26. pii: 10.1038/s41591-018-0186.
    >> Share

  26. ACKERMAN ME, Das J, Pittala S, Broge T, et al
    Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV.
    Nat Med. 2018 Sep 3. pii: 10.1038/s41591-018-0161.
    >> Share

  27. STOWER H
    An option for treatment of multidrug-resistant HIV.
    Nat Med. 2018;24:1303.
    >> Share

    August 2018
  28. OKOYE AA, Hansen SG, Vaidya M, Fukazawa Y, et al
    Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
    Nat Med. 2018 Aug 6. pii: 10.1038/s41591-018-0130.
    >> Share

    July 2018
  29. ORTIZ AM, Flynn JK, DiNapoli SR, Vujkovic-Cvijin I, et al
    Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques.
    Nat Med. 2018 Jul 30. pii: 10.1038/s41591-018-0132.
    >> Share

    June 2018
  30. COLBY DJ, Trautmann L, Pinyakorn S, Leyre L, et al
    Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.
    Nat Med. 2018 Jun 11. pii: 10.1038/s41591-018-0026.
    >> Share

  31. XU K, Acharya P, Kong R, Cheng C, et al
    Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.
    Nat Med. 2018;24:857-867.
    >> Share

    May 2018
  32. VACCARI M, Fourati S, Gordon SN, Brown DR, et al
    HIV vaccine candidate activation of hypoxia and the inflammasome in CD14(+) monocytes is associated with a decreased risk of SIVmac251 acquisition.
    Nat Med. 2018 May 21. pii: 10.1038/s41591-018-0025.
    >> Share

    April 2018
  33. COHN LB, da Silva IT, Valieris R, Huang AS, et al
    Clonal CD4(+) T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.
    Nat Med. 2018 Apr 23. pii: 10.1038/s41591-018-0017.
    >> Share

  34. GAUTAM R, Nishimura Y, Gaughan N, Gazumyan A, et al
    A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection.
    Nat Med. 2018 Apr 16. pii: 10.1038/s41591-018-0001.
    >> Share

    A tale of two diseases: Aging HIV patients inspire a closer look at Alzheimer's disease.
    Nat Med. 2018;24:376-377.
    >> Share

  36. HOPE TJ
    Inflammation weakens HIV prevention.
    Nat Med. 2018;24:384-385.
    >> Share

    February 2018
  37. MCKINNON LR, Liebenberg LJ, Yende-Zuma N, Archary D, et al
    Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women.
    Nat Med. 2018 Feb 26. pii: nm.4506. doi: 10.1038/nm.4506.
    >> Share

    January 2018
  38. HANSEN SG, Zak DE, Xu G, Ford JC, et al
    Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
    Nat Med. 2018 Jan 15. pii: nm.4473. doi: 10.1038/nm.4473.
    >> Share

    November 2017
  39. BUNDERS MJ, Altfeld M
    Can NK cells purge HIV sanctuaries?
    Nat Med. 2017;23:1254-1255.
    >> Share

    October 2017
  40. HUOT N, Jacquelin B, Garcia-Tellez T, Rascle P, et al
    Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys.
    Nat Med. 2017 Oct 16. doi: 10.1038/nm.4421.
    >> Share

  41. ESTES JD, Kityo C, Ssali F, Swainson L, et al
    Defining total-body AIDS-virus burden with implications for curative strategies.
    Nat Med. 2017 Oct 2. doi: 10.1038/nm.4411.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016